DeepSeek's Inference Gauntlet, OpenAI Buys Into Biopharma, Claude vs. Scorpions
About this episode
DeepSeek open-sources DeepInfer production inference engine with 155T tokens/day benchmark, OpenAI acquires Orchestra Bio to build end-to-end life sciences AI stack, Anthropic's Claude autonomously designs 17 validated scorpion-toxin protein binders in 64-hour campaign
Chapters
Sources & Citations
DeepSeek Open-Sources DeepInfer, the Inference Framework Behind DeepSeek-V4.1-Flash — MarkTechPost
www.marktechpost.com
DeepSeek open-sources DeepInfer, the inference engine behind its production models — CryptoBriefing
cryptobriefing.com
DeepSeek Open-Sources Its Inference Engine, Withholds Cost-Saving Components — TechTimes
www.techtimes.com
[AINews] DeepSeek DeepInfer: Open Source SOTA Inference running 155T toks/day — Latent Space
www.latent.space
OpenAI to acquire Orchestra Bio
openai.com
OpenAI acquires startup Orchestra Bio to beef up its biotech business | TechCrunch
techcrunch.com
Exclusive: OpenAI has acquired Orchestra Bio | Axios
www.axios.com
OpenAI acquires Orchestra Bio to bring AI agents into drug development | SiliconANGLE
siliconangle.com
How Claude designed protein binders against scorpion neurotoxins | Anthropic Research
www.anthropic.com
Autonomous De Novo Protein Binder Design with Claude (technical paper) | Anthropic / CDN
www-cdn.anthropic.com
Claude's 64-hour experiment finds 17 binders for scorpion toxins | Interesting Engineering
interestingengineering.com
Anthropic Claude Generates 318K+ Protein Designs via Autonomous Campaign | @venturesintern on X
x.com
Loading transcript…